It often takes many years before a new active compound from basic research hits the market as a drug. In order to accelerate this process, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Saarland...
On 9 September 2021, the 13th TWINCORE Symposium took place. This year, too, the event was held online due to corona. Nevertheless, the webinar was a great success and attracted even more viewers than last year.
...
The Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) is supporting the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg - an institution of the...
Nitric oxide (NO) occurs naturally in the human body as a messenger substance. It is considered an all-rounder, as it performs numerous important regulatory functions, including immune defense against pathogens. The...
New antibiotics are urgently needed in the fight against multi-resistant bacteria. The recently discovered darobactin is a potential candidate with resistance-breaking properties. This substance shows very good...
Hepatitis B is a viral infection of the liver that can lead to cancer and organ failure. Antiviral therapies can suppress the infection, but a functional cure is rare. Novel immunotherapies may lead to an actual cure...
EMBL and the six Helmholtz Centers of the Research Field Health (Helmholtz Health) are expanding their collaboration. The two research organisations are cooperating to expand the frontiers of health research and advance...
The Helmholtz Centre for Infection Research (HZI) in Braunschweig and the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) at McGill University in Montréal, Canada, are organising a joint symposium on...
